Cargando…
Myelodysplastic syndrome patient-derived xenografts: from no options to many
Autores principales: | Côme, Christophe, Balhuizen, Alexander, Bonnet, Dominique, Porse, Bo T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109759/ https://www.ncbi.nlm.nih.gov/pubmed/32193253 http://dx.doi.org/10.3324/haematol.2019.233320 |
Ejemplares similares
-
Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome
por: Soper, John, et al.
Publicado: (2022) -
Copper deficiency mimicking myelodysplastic syndrome
por: D'Angelo, Guido
Publicado: (2016) -
Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021) -
Old Dogs, New Tricks: Revisiting Immune Modulatory Approaches for Myelodysplastic Syndromes
por: Götze, Katharina S., et al.
Publicado: (2018) -
Molecular dissection of engraftment in a xenograft model of myelodysplastic syndromes
por: Meunier, Mathieu, et al.
Publicado: (2018)